Proactiveinvestors Australia Pharmaxis Ltd https://www.proactiveinvestors.com.au Proactiveinvestors Australia Pharmaxis Ltd RSS feed en Mon, 23 Sep 2019 15:56:52 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - Pharmaxis features in APAC’s top 100 most innovative pharma companies report ]]> https://www.proactiveinvestors.com.au/companies/news/902531/pharmaxis-features-in-apacs-top-100-most-innovative-pharma-companies-report-902531.html Thu, 12 Sep 2019 10:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/902531/pharmaxis-features-in-apacs-top-100-most-innovative-pharma-companies-report-902531.html <![CDATA[News - Pharmaxis hopeful of FDA approval for cystic fibrosis inhalation medicine Bronchitol by Q1 2020 ]]> https://www.proactiveinvestors.com.au/companies/news/900583/pharmaxis-hopeful-of-fda-approval-for-cystic-fibrosis-inhalation-medicine-bronchitol-by-q1-2020-900583.html Tue, 13 Aug 2019 12:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900583/pharmaxis-hopeful-of-fda-approval-for-cystic-fibrosis-inhalation-medicine-bronchitol-by-q1-2020-900583.html <![CDATA[News - Pharmaxis continues to add value to portfolio assets; Bronchitol reaches pivotal stage ]]> https://www.proactiveinvestors.com.au/companies/news/224464/pharmaxis-continues-to-add-value-to-portfolio-assets-bronchitol-reaches-pivotal-stage-224464.html Thu, 25 Jul 2019 13:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/224464/pharmaxis-continues-to-add-value-to-portfolio-assets-bronchitol-reaches-pivotal-stage-224464.html <![CDATA[News - Pharmaxis on track to complete FDA approval process for Bronchitol in Q1 2020 ]]> https://www.proactiveinvestors.com.au/companies/news/222458/pharmaxis-on-track-to-complete-fda-approval-process-for-bronchitol-in-q1-2020-222458.html Thu, 20 Jun 2019 12:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222458/pharmaxis-on-track-to-complete-fda-approval-process-for-bronchitol-in-q1-2020-222458.html <![CDATA[News - Pharmaxis expects an FDA decision on Bronchitol mid-year after positive committee recommendation ]]> https://www.proactiveinvestors.com.au/companies/news/313328/pharmaxis-expects-an-fda-decision-on-bronchitol-mid-year-after-positive-committee-recommendation-13328.html Mon, 13 May 2019 20:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313328/pharmaxis-expects-an-fda-decision-on-bronchitol-mid-year-after-positive-committee-recommendation-13328.html <![CDATA[News - Pharmaxis welcomes US FDA committee’s recommendation on use of Bronchitol in CF ]]> https://www.proactiveinvestors.com.au/companies/news/219929/pharmaxis-welcomes-us-fda-committees-recommendation-on-use-of-bronchitol-in-cf-219929.html Wed, 08 May 2019 22:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219929/pharmaxis-welcomes-us-fda-committees-recommendation-on-use-of-bronchitol-in-cf-219929.html <![CDATA[News - Pharmaxis prepares for advisory committee meeting on use of Bronchitol in the US ]]> https://www.proactiveinvestors.com.au/companies/news/217177/pharmaxis-prepares-for-advisory-committee-meeting-on-use-of-bronchitol-in-the-us-217177.html Tue, 26 Mar 2019 13:12:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217177/pharmaxis-prepares-for-advisory-committee-meeting-on-use-of-bronchitol-in-the-us-217177.html <![CDATA[News - Pharmaxis gains new substantial holder with 6.89% interest ]]> https://www.proactiveinvestors.com.au/companies/news/215758/pharmaxis-gains-new-substantial-holder-with-689-interest-215758.html Mon, 04 Mar 2019 19:57:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215758/pharmaxis-gains-new-substantial-holder-with-689-interest-215758.html <![CDATA[News - Pharmaxis sees progress in Boehringer Ingelheim’s clinical trial in patients with NASH ]]> https://www.proactiveinvestors.com.au/companies/news/215174/pharmaxis-sees-progress-in-boehringer-ingelheims-clinical-trial-in-patients-with-nash-215174.html Mon, 25 Feb 2019 14:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215174/pharmaxis-sees-progress-in-boehringer-ingelheims-clinical-trial-in-patients-with-nash-215174.html <![CDATA[News - Pharmaxis begins phase one clinical trial of compound targeting pancreatic cancer ]]> https://www.proactiveinvestors.com.au/companies/news/215089/pharmaxis-begins-phase-one-clinical-trial-of-compound-targeting-pancreatic-cancer-215089.html Fri, 22 Feb 2019 14:57:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215089/pharmaxis-begins-phase-one-clinical-trial-of-compound-targeting-pancreatic-cancer-215089.html <![CDATA[News - Pharmaxis well funded as potential partners assess its anti‐fibrotic mechanisms ]]> https://www.proactiveinvestors.com.au/companies/news/213663/pharmaxis-well-funded-as-potential-partners-assess-its-antifibrotic-mechanisms-213663.html Wed, 30 Jan 2019 21:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213663/pharmaxis-well-funded-as-potential-partners-assess-its-antifibrotic-mechanisms-213663.html <![CDATA[News - Pharmaxis LOXL2 program phase 2 ready after completion of 13-week toxicity studies ]]> https://www.proactiveinvestors.com.au/companies/news/212738/pharmaxis-loxl2-program-phase-2-ready-after-completion-of-13-week-toxicity-studies-212738.html Thu, 17 Jan 2019 13:21:00 +1100 https://www.proactiveinvestors.com.au/companies/news/212738/pharmaxis-loxl2-program-phase-2-ready-after-completion-of-13-week-toxicity-studies-212738.html <![CDATA[News - Pharmaxis resubmits new drug application for Bronchitol in the US ]]> https://www.proactiveinvestors.com.au/companies/news/211533/pharmaxis-resubmits-new-drug-application-for-bronchitol-in-the-us-211533.html Thu, 20 Dec 2018 13:47:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211533/pharmaxis-resubmits-new-drug-application-for-bronchitol-in-the-us-211533.html <![CDATA[News - Pharmaxis reveals first sales of Aridol® in US following successful relaunch ]]> https://www.proactiveinvestors.com.au/companies/news/211098/pharmaxis-reveals-first-sales-of-aridol-in-us-following-successful-relaunch-211098.html Thu, 13 Dec 2018 11:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211098/pharmaxis-reveals-first-sales-of-aridol-in-us-following-successful-relaunch-211098.html <![CDATA[News - Pharmaxis advancing partnership talks for LOXL2, starting pancreatic cancer program ]]> https://www.proactiveinvestors.com.au/companies/news/311300/pharmaxis-advancing-partnership-talks-for-loxl2-starting-pancreatic-cancer-program-11300.html Fri, 23 Nov 2018 14:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311300/pharmaxis-advancing-partnership-talks-for-loxl2-starting-pancreatic-cancer-program-11300.html <![CDATA[News - Pharmaxis moving into phase I clinical trial of its small molecule LOX inhibitor ]]> https://www.proactiveinvestors.com.au/companies/news/209514/pharmaxis-moving-into-phase-i-clinical-trial-of-its-small-molecule-lox-inhibitor-209514.html Tue, 20 Nov 2018 13:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/209514/pharmaxis-moving-into-phase-i-clinical-trial-of-its-small-molecule-lox-inhibitor-209514.html <![CDATA[News - Pharmaxis receives positive results from clinical trial of treatment for fibrotic diseases ]]> https://www.proactiveinvestors.com.au/companies/news/209233/pharmaxis-receives-positive-results-from-clinical-trial-of-treatment-for-fibrotic-diseases-209233.html Thu, 15 Nov 2018 10:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/209233/pharmaxis-receives-positive-results-from-clinical-trial-of-treatment-for-fibrotic-diseases-209233.html <![CDATA[News - Pharmaxis receives positive results from LOXL2 clinical trial ]]> https://www.proactiveinvestors.com.au/companies/news/206839/pharmaxis-receives-positive-results-from-loxl2-clinical-trial-206839.html Thu, 11 Oct 2018 12:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/206839/pharmaxis-receives-positive-results-from-loxl2-clinical-trial-206839.html <![CDATA[News - Pharmaxis adds valuable experience with Ed Rayner appointment ]]> https://www.proactiveinvestors.com.au/companies/news/205073/pharmaxis-adds-valuable-experience-with-ed-rayner-appointment-205073.html Tue, 18 Sep 2018 12:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/205073/pharmaxis-adds-valuable-experience-with-ed-rayner-appointment-205073.html <![CDATA[News - Pharmaxis gains Arix Bioscience Plc as a new substantial shareholder ]]> https://www.proactiveinvestors.com.au/companies/news/203235/pharmaxis-gains-arix-bioscience-plc-as-a-new-substantial-shareholder-203235.html Tue, 21 Aug 2018 08:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/203235/pharmaxis-gains-arix-bioscience-plc-as-a-new-substantial-shareholder-203235.html <![CDATA[News - Pharmaxis receives FDA approval to produce Aridol for US market ]]> https://www.proactiveinvestors.com.au/companies/news/202908/pharmaxis-receives-fda-approval-to-produce-aridol-for-us-market-202908.html Wed, 15 Aug 2018 12:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202908/pharmaxis-receives-fda-approval-to-produce-aridol-for-us-market-202908.html <![CDATA[News - Pharmaxis secures $24 million at premium to support partnering negotiations ]]> https://www.proactiveinvestors.com.au/companies/news/202252/pharmaxis-secures-24-million-at-premium-to-support-partnering-negotiations-202252.html Mon, 06 Aug 2018 13:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202252/pharmaxis-secures-24-million-at-premium-to-support-partnering-negotiations-202252.html <![CDATA[News - Pharmaxis enters trading halt ahead of share placement ]]> https://www.proactiveinvestors.com.au/companies/news/202159/pharmaxis-enters-trading-halt-ahead-of-share-placement-202159.html Fri, 03 Aug 2018 11:41:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202159/pharmaxis-enters-trading-halt-ahead-of-share-placement-202159.html <![CDATA[News - Pharmaxis powering ahead with phase I LOXL2 studies ]]> https://www.proactiveinvestors.com.au/companies/news/201702/pharmaxis-powering-ahead-with-phase-i-loxl2-studies-201702.html Fri, 27 Jul 2018 14:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/201702/pharmaxis-powering-ahead-with-phase-i-loxl2-studies-201702.html <![CDATA[News - Pharmaxis phase I trial attracts interest from multiple pharmaceutical companies ]]> https://www.proactiveinvestors.com.au/companies/news/198827/pharmaxis-phase-i-trial-attracts-interest-from-multiple-pharmaceutical-companies-198827.html Thu, 14 Jun 2018 11:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198827/pharmaxis-phase-i-trial-attracts-interest-from-multiple-pharmaceutical-companies-198827.html <![CDATA[News - Pharmaxis has the "secret sauce" for developing drugs through to commercialisation ]]> https://www.proactiveinvestors.com.au/companies/news/309343/pharmaxis-has-the-secret-sauce-for-developing-drugs-through-to-commercialisation-9343.html Tue, 22 May 2018 09:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309343/pharmaxis-has-the-secret-sauce-for-developing-drugs-through-to-commercialisation-9343.html <![CDATA[News - Pharmaxis has key drivers in place for short and long term value creation ]]> https://www.proactiveinvestors.com.au/companies/news/309289/pharmaxis-has-key-drivers-in-place-for-short-and-long-term-value-creation-9289.html Tue, 15 May 2018 10:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309289/pharmaxis-has-key-drivers-in-place-for-short-and-long-term-value-creation-9289.html <![CDATA[News - Pharmaxis boosts cash position securing sustainable future ]]> https://www.proactiveinvestors.com.au/companies/news/196009/pharmaxis-boosts-cash-position-securing-sustainable-future-196009.html Mon, 30 Apr 2018 14:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196009/pharmaxis-boosts-cash-position-securing-sustainable-future-196009.html <![CDATA[News - Pharmaxis reveals a quarterly shareholder update full of highlights ]]> https://www.proactiveinvestors.com.au/companies/news/309162/pharmaxis-reveals-a-quarterly-shareholder-update-full-of-highlights-9162.html Mon, 30 Apr 2018 10:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309162/pharmaxis-reveals-a-quarterly-shareholder-update-full-of-highlights-9162.html <![CDATA[News - Pharmaxis seeing a great deal of interest from potential LOXL2 program partners ]]> https://www.proactiveinvestors.com.au/companies/news/308729/pharmaxis-seeing-a-great-deal-of-interest-from-potential-loxl2-program-partners-8729.html Sun, 11 Feb 2018 20:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308729/pharmaxis-seeing-a-great-deal-of-interest-from-potential-loxl2-program-partners-8729.html <![CDATA[News - Pharmaxis making strong progress with significant value inflection points ahead ]]> https://www.proactiveinvestors.com.au/companies/news/308711/pharmaxis-making-strong-progress-with-significant-value-inflection-points-ahead-8711.html Wed, 07 Feb 2018 04:09:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308711/pharmaxis-making-strong-progress-with-significant-value-inflection-points-ahead-8711.html <![CDATA[News - Pharmaxis outlines share price catalysts for 2018 ]]> https://www.proactiveinvestors.com.au/companies/news/190782/pharmaxis-outlines-share-price-catalysts-for-2018-190782.html Tue, 30 Jan 2018 08:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190782/pharmaxis-outlines-share-price-catalysts-for-2018-190782.html <![CDATA[News - Pharmaxis strengthens balance sheet with $15 million milestone payment ]]> https://www.proactiveinvestors.com.au/companies/news/189839/pharmaxis-strengthens-balance-sheet-with-15-million-milestone-payment-189839.html Thu, 11 Jan 2018 11:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/189839/pharmaxis-strengthens-balance-sheet-with-15-million-milestone-payment-189839.html <![CDATA[News - Pharmaxis secures further Australian government reimbursement for Bronchitol ]]> https://www.proactiveinvestors.com.au/companies/news/189417/pharmaxis-secures-further-australian-government-reimbursement-for-bronchitol-189417.html Wed, 03 Jan 2018 09:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/189417/pharmaxis-secures-further-australian-government-reimbursement-for-bronchitol-189417.html <![CDATA[News - Pharmaxis takes full control of collaboration on LOXL2 inhibitors and expands scientific program ]]> https://www.proactiveinvestors.com.au/companies/news/188760/pharmaxis-takes-full-control-of-collaboration-on-loxl2-inhibitors-and-expands-scientific-program-188760.html Thu, 14 Dec 2017 11:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188760/pharmaxis-takes-full-control-of-collaboration-on-loxl2-inhibitors-and-expands-scientific-program-188760.html <![CDATA[News - Synairgen shoots higher on new terms for fibrosis collaboration ]]> https://www.proactiveinvestors.com.au/companies/news/188777/synairgen-shoots-higher-on-new-terms-for-fibrosis-collaboration-188777.html Thu, 14 Dec 2017 07:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188777/synairgen-shoots-higher-on-new-terms-for-fibrosis-collaboration-188777.html <![CDATA[News - Pharmaxis boosts its drug discovery ranks ]]> https://www.proactiveinvestors.com.au/companies/news/185843/pharmaxis-boosts-its-drug-discovery-ranks-185843.html Thu, 19 Oct 2017 16:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185843/pharmaxis-boosts-its-drug-discovery-ranks-185843.html <![CDATA[News - Pharmaxis' CEO Gary Phillips updates on partnership with Boehringer Ingelheim ]]> https://www.proactiveinvestors.com.au/companies/news/308045/pharmaxis-ceo-gary-phillips-updates-on-partnership-with-boehringer-ingelheim-8045.html Fri, 08 Sep 2017 08:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/308045/pharmaxis-ceo-gary-phillips-updates-on-partnership-with-boehringer-ingelheim-8045.html <![CDATA[News - Pharmaxis is set to commence phase 1 trials ]]> https://www.proactiveinvestors.com.au/companies/news/308042/pharmaxis-is-set-to-commence-phase-1-trials-8042.html Thu, 07 Sep 2017 07:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/308042/pharmaxis-is-set-to-commence-phase-1-trials-8042.html <![CDATA[News - Lots of potential for Synairgen in fibrosis, suggests broker finncap ]]> https://www.proactiveinvestors.com.au/companies/news/183540/lots-of-potential-for-synairgen-in-fibrosis-suggests-broker-finncap-183540.html Wed, 06 Sep 2017 12:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183540/lots-of-potential-for-synairgen-in-fibrosis-suggests-broker-finncap-183540.html <![CDATA[News - Pharmaxis and collaborator Synairgen advance towards human clinical studies ]]> https://www.proactiveinvestors.com.au/companies/news/183502/pharmaxis-and-collaborator-synairgen-advance-towards-human-clinical-studies-183502.html Wed, 06 Sep 2017 11:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183502/pharmaxis-and-collaborator-synairgen-advance-towards-human-clinical-studies-183502.html <![CDATA[News - Pharmaxis' largest shareholder BVF Partners LP lifts stake ]]> https://www.proactiveinvestors.com.au/companies/news/183128/pharmaxis-largest-shareholder-bvf-partners-lp-lifts-stake-183128.html Wed, 30 Aug 2017 11:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183128/pharmaxis-largest-shareholder-bvf-partners-lp-lifts-stake-183128.html <![CDATA[News - Pharmaxis gets A$27M injection from Boehringer Ingelheim ]]> https://www.proactiveinvestors.com.au/companies/news/307997/pharmaxis-gets-a27m-injection-from-boehringer-ingelheim-7997.html Mon, 28 Aug 2017 08:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307997/pharmaxis-gets-a27m-injection-from-boehringer-ingelheim-7997.html <![CDATA[News - Pharmaxis to receive cash injection as Boehringer Ingelheim initiates new trials ]]> https://www.proactiveinvestors.com.au/companies/news/182963/pharmaxis-to-receive-cash-injection-as-boehringer-ingelheim-initiates-new-trials-182963.html Fri, 25 Aug 2017 12:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/182963/pharmaxis-to-receive-cash-injection-as-boehringer-ingelheim-initiates-new-trials-182963.html <![CDATA[News - Pharmaxis receives support for expanded reimbursement of its drug Bronchitol® ]]> https://www.proactiveinvestors.com.au/companies/news/182706/pharmaxis-receives-support-for-expanded-reimbursement-of-its-drug-bronchitol-182706.html Mon, 21 Aug 2017 13:36:00 +1000 https://www.proactiveinvestors.com.au/companies/news/182706/pharmaxis-receives-support-for-expanded-reimbursement-of-its-drug-bronchitol-182706.html <![CDATA[News - Pharmaxis enters new quarter positioned for growth ]]> https://www.proactiveinvestors.com.au/companies/news/181609/pharmaxis-enters-new-quarter-positioned-for-growth-181609.html Fri, 28 Jul 2017 12:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181609/pharmaxis-enters-new-quarter-positioned-for-growth-181609.html <![CDATA[News - Pharmaxis Ltd's Gary Phillips reveals completed Phase 3 clinical trial of Bronchitol ]]> https://www.proactiveinvestors.com.au/companies/news/307624/pharmaxis-ltd-s-gary-phillips-reveals-completed-phase-3-clinical-trial-of-bronchitol-7624.html Tue, 13 Jun 2017 10:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307624/pharmaxis-ltd-s-gary-phillips-reveals-completed-phase-3-clinical-trial-of-bronchitol-7624.html <![CDATA[News - Pharmaxis appoints highly-experienced Dr Kathleen Metters to the board ]]> https://www.proactiveinvestors.com.au/companies/news/178932/pharmaxis-appoints-highly-experienced-dr-kathleen-metters-to-the-board-178932.html Thu, 08 Jun 2017 09:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/178932/pharmaxis-appoints-highly-experienced-dr-kathleen-metters-to-the-board-178932.html <![CDATA[News - Pharmaxis shares close higher on new cash payment ]]> https://www.proactiveinvestors.com.au/companies/news/177821/pharmaxis-shares-close-higher-on-new-cash-payment-177821.html Tue, 16 May 2017 09:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177821/pharmaxis-shares-close-higher-on-new-cash-payment-177821.html